![](https://www.ataxia.org/wp-content/uploads/2022/07/pexels-photo-263370-1024x682-1-300x200.jpeg)
Approaching the age of clinical therapy for spinocerebellar ataxia type 1
Written by Dr. Marija Cvetanovic Edited by Dr. Maxime W. Rousseaux New research (published Nov. 2018) reveals promising potential genetic therapy for SCA1. A research team comprised of scientists from academia and industry have tested a new treatment for Spinocerebellar ataxia type 1 (SCA1), bringing disease-modifying therapy one step closer Read More…